Home›People›Barbara Fox
BF

Barbara Fox

Chair at Alphina Therapeutics. Also a board director at Myris Therapeutics.

ExecutiveDirectorRoles at 2 startups
Updated Nov 10, 2026·Latest SEC filing Oct 14, 2026·Suggest an edit

About Barbara Fox

Barbara Fox is a chair at Alphina Therapeutics.

Form D filings also name Barbara Fox as a board director at Myris Therapeutics.

Experience

This experience comes from Barbara Fox's profile and from SEC filings. For roles taken from filings, the years are when the filings name Barbara Fox in the role, so the role may have started earlier or lasted longer.

Alphina Therapeutics, Inc. Current
Independent Board Chair
2024 – Present · New Haven, CT
Develops cancer drugs and a patient-selection test for people with solid tumors.
Myris Therapeutics, Inc. Current
Independent Board Member
2023 – Present · Sharpsburg, PA
Develops antibody-linked medicines for people with cancer.
Diagonal Therapeutics Current
Independent Board Member
2022 – Present
Rheos Medicines
Chief Executive Officer (consulting)
2019 – 2023
AnTolRx, Inc.
Independent Board Member
2017 – 2019
Tilos Therapeutics
Consultant
2016 – 2019
Partners Innovation Fund
Entrepreneur in Residence
2016
Avaxia Biologics
CEO
2005 – 2015
Oxford Bioscience partners
Affiliate Entrepreneur
2004 – 2006
Recovery Pharmaceuticals
President, Founder, Chief Scientific Officer
1998 – 2003
ImmuLogic Pharmaceutical Corp.
Vice President, Discovery Research and Immunology
1993 – 1998
University of Maryland School of Medicine
Associate Professor of Medicine with tenure
1987 – 1993
NIH
Post-doctoral fellow
1983 – 1987
MIT
Ph.D., Chemistry
1979 – 1983
Bryn Mawr College
B.A., Chemistry
1974 – 1978

Key Colleagues at Startups

The people Barbara Fox works with at each company, as listed on that company's latest Form D.

Myris Therapeutics, Inc. · Form D, Oct 14, 2026
Laura Benjamin
Laura Benjamin
CEO, Board Director
RW
Rebecca Wolfe
Executive officer
AS
Antonina Simakova
Executive officer
Alan Russell
Alan Russell
Promoter
David Colaizzi
David Colaizzi
Board Chairman
Krzysztof Matyjaszewski
Krzysztof Matyjaszewski
Co-Founder and Board Director
Mark Murcko
Mark Murcko
Board Director
Alphina Therapeutics, Inc. · Form D, Mar 16, 2026
CC
Colleen Cuffaro
Member of Alphina's Board
NG
Nicholas Galli
Chief Executive Officer and director
KR
Kevin Rakin
Director
MC
RB

Sources

  1. SECMyris Therapeutics, Inc. Form D, filed Oct 14, 2026
  2. SECAlphina Therapeutics, Inc. Form D, filed Mar 16, 2026